Series B funding round for Curebase raising $40M in May 2022
Series B funding round for Curebase raising $40M in May 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Dave Pell |
| Angel | Mathieu Guerville |
| Angel | Patrick S. Chung |
| Angel | Greg Schroy |
| Angel | John M. Mueller |
| Angel | Michael Lombardi |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$58M
Top Valuation
-
Curebase raised $40M in a Series B round.
The round was announced on 05/01/22.